-+ 0.00%
-+ 0.00%
-+ 0.00%

CONNECT BIOPHARMA - EXPECTS TOPLINE RESULTS FROM PHASE 2 SEABREEZE STAT STUDIES IN SEPTEMBER 2026

Reuters·08/12/2026 20:05:01

Please log in to view news